Apelin inhibits the development of diabetic nephropathy by regulating histone acetylation in Akita mouse

Journal of Physiology

Volumn 592, Issue 3, 2014, Pages 505-521

  Chen, Hong ^a   Li, Jianshuang ^b   Jiao, Lihua ^a   Petersen, Robert B ^c   Li, Jiong ^b   Peng, Anlin ^d   Zheng, Ling ^b   Huang, Kun ^a,e  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b WUHAN UNIVERSITY   (China)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d TONGREN HOSPITAL OF WUHAN UNIVERSITY   (China)

^e Wuhan Institute of Biotechnology   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLATION; ANIMALS; DIABETIC NEPHROPATHIES; GLOMERULAR FILTRATION RATE; HISTONES; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; NF-KAPPA B; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 84893428715     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2013.266411     Document Type: Article

References (49)

1. Advani A, Huang Q, Thai K, Advani SL, White KE, Kelly DJ, Yuen DA, Connelly KA, Marsden PA & Gilbert RE (2011). Long-term administration of the histone deacetylase inhibitor vorinostat attenuates renal injury in experimental diabetes through an endothelial nitric oxide synthase-dependent mechanism. Am J Pathol 178, 2205-2214.
2. Akcilar R, Turgut S, Caner V, Akcilar A, Ayada C, Elmas L & Ozcan TO (2013). Apelin effects on blood pressure and RAS in DOCA-salt-induced hypertensive rats. Clin Exp Hypertens 35, 550-557.
3. Alkhalaf A, Kleefstra N, Groenier KH, Bilo HJ, Gans RO, Heeringa P, Scheijen JL, Schalkwijk CG, Navis GJ & Bakker SJ (2012). Effect of benfotiamine on advanced glycation endproducts and markers of endothelial dysfunction and inflammation in diabetic nephropathy. PLoS One 7, e40427.
4. Chen H, Zheng C, Zhang X, Li J, Zheng L & Huang K (2011). Apelin alleviates diabetes-associated endoplasmic reticulum stress in the pancreas of Akita mice. Peptides 32, 1634-1639.
5. Chen MM, Ashley EA, Deng DX, Tsalenko A, Deng A, Tabibiazar R, Ben-Dor A, Fenster B, Yang E, King JY, Fowler M, Robbins R, Johnson FL, Bruhn L, McDonagh T, Dargie H, Yakhini Z, Tsao PS & Quertermous T (2003). Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction. Circulation 108, 1432-1439.
6. Chow FY, Nikolic-Paterson DJ, Ma FY, Ozols E, Rollins BJ & Tesch GH (2007). Monocyte chemoattractant protein-1-induced tissue inflammation is critical for the development of renal injury but not type 2 diabetes in obese db/db mice. Diabetologia 50, 471-480.
7. Chow FY, Nikolic-Paterson DJ, Ozols E, Atkins RC & Tesch GH (2005). Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice. J Am Soc Nephrol 16, 1711-1722.
8. Cooper ME (2001). Interaction of metabolic and haemodynamic factors in mediating experimental diabetic nephropathy. Diabetologia 44, 1957-1972.
9. Day RT, Cavaglieri RC & Feliers D (2013). Apelin retards the progression of diabetic nephropathy. Am J Physiol Renal Physiol 304, F788-F800.
10. Ding Y, Li J, Liu S, Zhang L, Xiao H, Chen H, Petersen RB, Huang K & Zheng L (2013). DNA hypomethylation of inflammation-associated genes in adipose tissue of female mice after multigenerational high fat diet feeding. Int J Obes (Lond) DOI: 10.1038/ijo.2013.98. (Epub ahead of print).
11. Dray C, Knauf C, Daviaud D, Waget A, Boucher J, Buleon M, Cani PD, Attane C, Guigne C, Carpene C, Burcelin R, Castan-Laurell I & Valet P (2008). Apelin stimulates glucose utilization in normal and obese insulin-resistant mice. Cell Metab 8, 437-445.
12. Edelstein LC, Pan A & Collins T (2005). Chromatin modification and the endothelial-specific activation of the E-selectin gene. J Biol Chem 280, 11192-11202.
13. Fish JE, Matouk CC, Rachlis A, Lin S, Tai SC, D'Abreo C & Marsden PA (2005). The expression of endothelial nitric-oxide synthase is controlled by a cell-specific histone code. J Biol Chem 280, 24824-24838.
14. Foundation NK (2002). K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 39, S1-S266.
15. Gaikwad AB, Gupta J & Tikoo K (2010). Epigenetic changes and alteration of Fbn1 and Col3A1 gene expression under hyperglycaemic and hyperinsulinaemic conditions. Biochem J 432, 333-341.
16. Jin Q, Yu LR, Wang L, Zhang Z, Kasper LH, Lee JE, Wang C, Brindle PK, Dent SY & Ge K (2011). Distinct roles of GCN5/PCAF-mediated H3K9ac and CBP/p300-mediated H3K18/27ac in nuclear receptor transactivation. EMBO J 30, 249-262.
17. Kadiyala CS, Zheng L, Du Y, Yohannes E, Kao HY, Miyagi M & Kern TS (2012). Acetylation of retinal histones in diabetes increases inflammatory proteins: effects of minocycline and manipulation of histone acetyltransferase (HAT) and histone deacetylase (HDAC). J Biol Chem 287, 25869-25880.
18. Kleinz MJ & Baxter GF (2008). Apelin reduces myocardial reperfusion injury independently of PI3K/Akt and P70S6 kinase. Regul Pept 146, 271-277.
19. Lane PH, Steffes MW & Mauer SM (1992). Estimation of glomerular volume: a comparison of four methods. Kidney Int 41, 1085-1089.
20. Li C, Wang L, Huang K & Zheng L (2012a). Endoplasmic reticulum stress in retinal vascular degeneration: protective role of resveratrol. Invest Ophthalmol Vis Sci 53, 3241-3249.
21. Li J, Huang J, Li JS, Chen H, Huang K & Zheng L (2012b). Accumulation of endoplasmic reticulum stress and lipogenesis in the liver through generational effects of high fat diets. J Hepatol 56, 900-907.
22. Medhurst AD, Jennings CA, Robbins MJ, Davis RP, Ellis C, Winborn KY, Lawrie KW, Hervieu G, Riley G, Bolaky JE, Herrity NC, Murdock P & Darker JG (2003). Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin. J Neurochem 84, 1162-1172.
23. Miao F, Gonzalo IG, Lanting L & Natarajan R (2004). In vivo chromatin remodeling events leading to inflammatory gene transcription under diabetic conditions. J Biol Chem 279, 18091-18097.
24. Najafipour H, Soltani Hekmat A, Nekooian AA & Esmaeili-Mahani S (2012). Apelin receptor expression in ischemic and non-ischemic kidneys and cardiovascular responses to apelin in chronic two-kidney-one-clip hypertension in rats. Regul Pept 178, 43-50.
25. Navarro-Gonzalez JF & Mora-Fernandez C (2008). The role of inflammatory cytokines in diabetic nephropathy. J Am Soc Nephrol 19, 433-442.
26. Noh H, Oh EY, Seo JY, Yu MR, Kim YO, Ha H & Lee HB (2009). Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-β1-induced renal injury. Am J Physiol Renal Physiol 297, F729-F739.
27. Pero R, Peluso S, Angrisano T, Tuccillo C, Sacchetti S, Keller S, Tomaiuolo R, Bruni CB, Lembo F & Chiariotti L (2011). Chromatin and DNA methylation dynamics of Helicobacter pylori-induced COX-2 activation. Int J Med Microbiol 301, 140-149.
28. Proctor G, Jiang T, Iwahashi M, Wang Z, Li J & Levi M (2006). Regulation of renal fatty acid and cholesterol metabolism, inflammation, and fibrosis in Akita and OVE26 mice with type 1 diabetes. Diabetes 55, 2502-2509.
29. Reaux A, De Mota N, Skultetyova I, Lenkei Z, El Messari S, Gallatz K, Corvol P, Palkovits M & Llorens-Cortes C (2001). Physiological role of a novel neuropeptide, apelin, and its receptor in the rat brain. J Neurochem 77, 1085-1096.
30. Reaux A, Gallatz K, Palkovits M & Llorens-Cortes C (2002). Distribution of apelin-synthesizing neurons in the adult rat brain. Neuroscience 113, 653-662.
31. Reddy MA, Sahar S, Villeneuve LM, Lanting L & Natarajan R (2009). Role of Src tyrosine kinase in the atherogenic effects of the 12/15-lipoxygenase pathway in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 29, 387-393.
32. Sagiroglu T, Torun N, Yagci M, Yalta T, Sagiroglu G & Oguz S (2012). Effects of apelin and leptin on renal functions following renal ischemia/reperfusion: An experimental study. Exp Ther Med 3, 908-914.
33. Sayyed SG, Gaikwad AB, Lichtnekert J, Kulkarni O, Eulberg D, Klussmann S, Tikoo K & Anders HJ (2010). Progressive glomerulosclerosis in type 2 diabetes is associated with renal histone H3K9 and H3K23 acetylation, H3K4 dimethylation and phosphorylation at serine 10. Nephrol Dial Transplant 25, 1811-1817.
34. Schena FP & Gesualdo L (2005). Pathogenetic mechanisms of diabetic nephropathy. J Am Soc Nephrol 16 (Suppl. 1), S30-33.
35. Shanmugam MK & Sethi G (2012). Role of epigenetics in inflammation-associated diseases. Subcell Biochem 61, 627-657.
36. Soltani Hekmat A, Najafipour H, Nekooian AA, Esmaeli-Mahani S & Javanmardi K (2011). Cardiovascular responses to apelin in two-kidney-one-clip hypertensive rats and its receptor expression in ischemic and non-ischemic kidneys. Regul Pept 172, 62-68.
37. Susztak K & Bottinger EP (2006). Diabetic nephropathy: a frontier for personalized medicine. J Am Soc Nephrol 17, 361-367.
38. Takeuchi M, Iwata M, Kiguchi M, Kaga M, Shimpo K & Tanabe T (1984). [Chronic toxicity study of AC-1370 sodium, an antibiotics, intravenously administered in rats]. J Toxicol Sci 9, 363-388.
39. Tarabra E, Giunti S, Barutta F, Salvidio G, Burt D, Deferrari G, Gambino R, Vergola D, Pinach S, Perin PC, Camussi G & Gruden G (2009). Effect of the monocyte chemoattractant protein-1/CC chemokine receptor 2 system on nephrin expression in streptozotocin-treated mice and human cultured podocytes. Diabetes 58, 2109-2118.
40. Tatemoto K, Hosoya M, Habata Y, Fujii R, Kakegawa T, Zou MX, Kawamata Y, Fukusumi S, Hinuma S, Kitada C, Kurokawa T, Onda H & Fujino M (1998). Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun 251, 471-476.
41. Toque HA, Nunes KP, Yao L, Xu Z, Kondrikov D, Su Y, Webb RC, Caldwell RB & Caldwell RW (2013). Akita spontaneously type 1 diabetic mice exhibit elevated vascular arginase and impaired vascular endothelial and nitrergic function. PLoS One 8, e72277.
42. Villeneuve LM, Reddy MA & Natarajan R (2011). Epigenetics: deciphering its role in diabetes and its chronic complications. Clin Exp Pharmacol Physiol 38, 451-459.
43. Vlassara H, Cai W, Chen X, Serrano EJ, Shobha MS, Uribarri J, Woodward M & Striker GE (2012). Managing chronic inflammation in the aging diabetic patient with CKD by diet or sevelamer carbonate: a modern paradigm shift. J Gerontol A Biol Sci Med Sci 67, 1410-1416.
44. Wang LL, Chen H, Huang K & Zheng L (2012). Elevated histone acetylations in Muller cell contribute to inflammation: a novel inhibitory effect of minocycline. Glia 60, 1896-1905.
45. Xu J, Xu W, Yao H, Sun W, Zhou Q & Cai L (2013). Associations of serum and urinary magnesium with the pre-diabetes, diabetes and diabetic complications in the Chinese Northeast population. PLoS One 8, e56750.
46. Yi X, Xu L, Hiller S, Kim HS, Nickeleit V, James LR & Maeda N (2012). Reduced expression of lipoic acid synthase accelerates diabetic nephropathy. J Am Soc Nephrol 23, 103-111.
47. Yoshioka M, Kayo T, Ikeda T & Koizumi A (1997). A novel locus, Mody4, distal to D7Mit189 on chromosome 7 determines early-onset NIDDM in nonobese C57BL/6 (Akita) mutant mice. Diabetes 46, 887-894.
48. Zager RA, Johnson AC & Becker K (2011). Acute unilateral ischemic renal injury induces progressive renal inflammation, lipid accumulation, histone modification, and 'end-stage' kidney disease. Am J Physiol Renal Physiol 301, F1334-F1345.
49. Zhao Q, Gu D, Kelly TN, Hixson JE, Rao DC, Jaquish CE, Chen J, Huang J, Chen CS, Gu CC, Whelton PK & He J (2010). Association of genetic variants in the apelin-APJ system and ACE2 with blood pressure responses to potassium supplementation: the GenSalt study. Am J Hypertens 23, 606-613.